
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities
Lizhuo Zhang, Qingqing Feng, Jiafeng Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188928-188928
Open Access | Times Cited: 33
Lizhuo Zhang, Qingqing Feng, Jiafeng Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188928-188928
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
Advances in Radioligand Theranostics in Oncology
Ismaheel O. Lawal, Sofiullah Abubakar, Honest Ndlovu, et al.
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 3, pp. 265-289
Closed Access | Times Cited: 11
Ismaheel O. Lawal, Sofiullah Abubakar, Honest Ndlovu, et al.
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 3, pp. 265-289
Closed Access | Times Cited: 11
Update on current diagnosis and management of anaplastic thyroid carcinoma
T. Pavlidis, I. Galanis, T. Pavlidis
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 12, pp. 570-583
Open Access | Times Cited: 12
T. Pavlidis, I. Galanis, T. Pavlidis
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 12, pp. 570-583
Open Access | Times Cited: 12
Prioritization of drug targets for thyroid cancer: a multi-omics Mendelian randomization study
Hong Sun, Ling Li, Jingchao Yan, et al.
Endocrine (2024) Vol. 86, Iss. 2, pp. 732-743
Closed Access | Times Cited: 4
Hong Sun, Ling Li, Jingchao Yan, et al.
Endocrine (2024) Vol. 86, Iss. 2, pp. 732-743
Closed Access | Times Cited: 4
Diagnosis and treatment of a rare bilateral primary thyroid cancer: a case report
Hai Lin, Xinyu Zhang, Na Yan, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Hai Lin, Xinyu Zhang, Na Yan, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
A new broom sweeps clean: CLDN16 surpasses the BRAF-V600E mutation as an unrivaled biomarker in papillary thyroid cancer
Yefeng Cai, Yawen Guo, Wenli Ma, et al.
European Journal of Endocrinology (2025) Vol. 192, Iss. 2, pp. 128-140
Closed Access
Yefeng Cai, Yawen Guo, Wenli Ma, et al.
European Journal of Endocrinology (2025) Vol. 192, Iss. 2, pp. 128-140
Closed Access
The potential mechanisms by which Xiaoyao Powder may exert therapeutic effects on thyroid cancer were examined at various levels
Xiaoli Lei, Feifei Wang, Xinying Zhang, et al.
Computational Biology and Chemistry (2025) Vol. 117, pp. 108412-108412
Closed Access
Xiaoli Lei, Feifei Wang, Xinying Zhang, et al.
Computational Biology and Chemistry (2025) Vol. 117, pp. 108412-108412
Closed Access
A rare case of rib chondrosarcoma with purely mesenchymal cells metastases to thyroid
Jia Wang, Fang Mei, Mingcheng Li, et al.
Diagnostic Pathology (2025) Vol. 20, Iss. 1
Open Access
Jia Wang, Fang Mei, Mingcheng Li, et al.
Diagnostic Pathology (2025) Vol. 20, Iss. 1
Open Access
Effect of radioactive iodine therapy on hematological parameters in patients with thyroid cancer: systematic review and meta-analysis
Dereje Mengesha Berta, Bisrat Birke Teketelew, Negesse Cherie, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Dereje Mengesha Berta, Bisrat Birke Teketelew, Negesse Cherie, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Antigen‐Targeting Inserted Nanomicelles Guide Pre‐Existing Immunity to Kill Head and Neck Cancer
Lizhuo Zhang, Qingqing Feng, Chuanming Zheng, et al.
Advanced Science (2025)
Open Access
Lizhuo Zhang, Qingqing Feng, Chuanming Zheng, et al.
Advanced Science (2025)
Open Access
PIS as a regulator of cellular heterogeneity, prognostic significance, and immune landscape in thyroid cancer
Xianjiang Wu, Lei Dai, Weidong Zhang, et al.
Translational Oncology (2025) Vol. 55, pp. 102296-102296
Closed Access
Xianjiang Wu, Lei Dai, Weidong Zhang, et al.
Translational Oncology (2025) Vol. 55, pp. 102296-102296
Closed Access
Tailoring TSH suppression in differentiated thyroid carcinoma: evidence, controversies, and future directions
Xinxin Song, Xin Zhi, Linxue Qian
Endocrine (2025)
Closed Access
Xinxin Song, Xin Zhi, Linxue Qian
Endocrine (2025)
Closed Access
Clinicopathological analysis of thyroid carcinomas with the RET and NTRK fusion genes: characterization for genetic analysis
Yoichiro Okubo, Soji Toda, Mei Kadoya, et al.
Virchows Archiv (2024) Vol. 485, Iss. 3, pp. 509-518
Open Access | Times Cited: 3
Yoichiro Okubo, Soji Toda, Mei Kadoya, et al.
Virchows Archiv (2024) Vol. 485, Iss. 3, pp. 509-518
Open Access | Times Cited: 3
Sorafenib Encapsulated Poly(ester amide) Nanoparticles for Efficient and Biosafe Prostate Cancer Therapy
Shunli Yu, Ruhe Zhang, Zhaoxiang Xie, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 7, pp. 4336-4346
Closed Access | Times Cited: 3
Shunli Yu, Ruhe Zhang, Zhaoxiang Xie, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 7, pp. 4336-4346
Closed Access | Times Cited: 3
ENO2 promotes anoikis resistance in anaplastic thyroid cancer by maintaining redox homeostasis
Yu Zhang, Xiaoyu Ji, Yu Wang
Gland Surgery (2024) Vol. 13, Iss. 2, pp. 209-224
Open Access | Times Cited: 2
Yu Zhang, Xiaoyu Ji, Yu Wang
Gland Surgery (2024) Vol. 13, Iss. 2, pp. 209-224
Open Access | Times Cited: 2
Human epidermal growth factor receptor 2(Her2)-targeted pH-responsive MR/NIRF bimodal imaging-mediated nano-delivery system for the diagnosis and treatment of undifferentiated thyroid cancer
Qiushi Jia, Fulin Li, Chunxiang Li, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 2
Qiushi Jia, Fulin Li, Chunxiang Li, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 2
Identification and clinical value of a new ceRNA axis (TIMP3/hsa‐miR‐181b‐5p/PAX8‐AS1) in thyroid cancer
Jiamin Liang, Yu Deng, Yubi Zhang, et al.
Health Science Reports (2024) Vol. 7, Iss. 2
Open Access | Times Cited: 1
Jiamin Liang, Yu Deng, Yubi Zhang, et al.
Health Science Reports (2024) Vol. 7, Iss. 2
Open Access | Times Cited: 1
Incorporating Network Pharmacology and Experimental Validation to Identify Bioactive Compounds and Potential Mechanisms of Digitalis in Treating Anaplastic Thyroid Cancer
Lei Zhu, Ruimin Liang, Yawen Guo, et al.
ACS Omega (2024) Vol. 9, Iss. 13, pp. 15590-15602
Open Access | Times Cited: 1
Lei Zhu, Ruimin Liang, Yawen Guo, et al.
ACS Omega (2024) Vol. 9, Iss. 13, pp. 15590-15602
Open Access | Times Cited: 1
Predictive biomarkers in thyroid cancer in the current molecular-morphology paradigm
Humberto Carneiro, Rodrigo de Andrade Natal, Evelin Cavalcante Farias, et al.
Surgical and Experimental Pathology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1
Humberto Carneiro, Rodrigo de Andrade Natal, Evelin Cavalcante Farias, et al.
Surgical and Experimental Pathology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1
Medullary thyroid cancer: single-cell transcriptome and tumor evolution
Lifeng Wang, Wen-Wen Zhou, Yuan Fang, et al.
Holistic Integrative Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 1
Lifeng Wang, Wen-Wen Zhou, Yuan Fang, et al.
Holistic Integrative Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 1
Bioinformatic identification reveals a m6A-binding protein, IGF2BP2, as a novel tumor-promoting gene signature in thyroid carcinoma
Yang Xie, Junqi Xiao, Yong Ying, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 5663-5676
Closed Access
Yang Xie, Junqi Xiao, Yong Ying, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 5663-5676
Closed Access
Editorial for the Special Issue “Molecular Biology in Targeted Radionuclide Therapy Radiopharmaceutical Design”
C. Aprile, Onelio Geatti, Letizia Canziani, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 3, pp. 2398-2401
Open Access
C. Aprile, Onelio Geatti, Letizia Canziani, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 3, pp. 2398-2401
Open Access
The Effects of Tetrahydrocurcumin on Adriamycin and Taxane resistance in Anaplastic Thyroid Cancer Cells
Mehmet Ali Koçdor, Yagmur Kaya, Halil Ateş, et al.
Research Square (Research Square) (2024)
Open Access
Mehmet Ali Koçdor, Yagmur Kaya, Halil Ateş, et al.
Research Square (Research Square) (2024)
Open Access
Molecular genetic markers of highly differentiated thyroid cancer (literature review and personal observations)
О. Yu. Usenko, І. П. Хоменко, Kovalenko Ae, et al.
The Ukrainian Journal of Clinical Surgery (2024) Vol. 90, Iss. 6, pp. 23-34
Open Access
О. Yu. Usenko, І. П. Хоменко, Kovalenko Ae, et al.
The Ukrainian Journal of Clinical Surgery (2024) Vol. 90, Iss. 6, pp. 23-34
Open Access
DPP4 Promotes Papillary Thyroid Cancer Progression by Regulating the Infiltration and Exhaustion of CD8+ T cells
Jing Ren, Nan Wu, Yang Wu, et al.
Research Square (Research Square) (2024)
Open Access
Jing Ren, Nan Wu, Yang Wu, et al.
Research Square (Research Square) (2024)
Open Access
Current status and perspectives of TMIGD2-targeted therapy in thyroid cancer
Kailin Zhao
MedScien (2024) Vol. 1, Iss. 8
Open Access
Kailin Zhao
MedScien (2024) Vol. 1, Iss. 8
Open Access